Head-to-head dispatch
AlyveRx vs RxSpan MD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
AlyveRx (Alyve, Inc.) is a US online telehealth platform connecting patients with licensed providers for GLP-1 weight loss care, no insurance required, with free discreet delivery.
Marked down on: Does not publicly name its dispensing pharmacy or display a LegitScript seal, so third-party accreditation is unverified
Desk Score
A physician-founded desk with one of the widest menus in the ranking — compounded and brand-name GLP-1 across injectable and oral routes, microdosing, plus longevity, hair, and sexual-health lines — with transparent, all-inclusive pricing across all 50 states.
Marked down on: Compounded semaglutide and tirzepatide are not FDA-approved — not the same as Wegovy/Ozempic or Zepbound
RxSpan MD takes this head-to-head with the higher Desk Score, 86/100 (B) against 69/100 (C) for AlyveRx. AlyveRx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
AlyveRx
69/100
C
RxSpan MD
86/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | AlyveRx | RxSpan MD |
|---|---|---|
| Semaglutide | $183/mo (all doses, compounded) | From $194/mo |
| Tirzepatide | $249/mo (all doses, compounded) | $329/mo |
| Coverage | Coverage not published | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | People who want needle-free sublingual GLP-1 options alongside standard compounded injections. | Patients who want a broad, physician-led menu across GLP-1 routes and adjacent longevity care, with transparent all-inclusive pricing and nationwide reach. |
| Desk Score | 69/100C | 86/100B |
The verdict
Desk pick — RxSpan MDRxSpan MD takes this head-to-head with the higher Desk Score, 86/100 (B) against 69/100 (C) for AlyveRx. AlyveRx still holds its ground where its strengths line up with yours.
Choose AlyveRx if…
People who want needle-free sublingual GLP-1 options alongside standard compounded injections.
$183/mo (all doses, compounded) sema · $249/mo (all doses, compounded) tirz · Coverage not published
Choose RxSpan MD if…
Patients who want a broad, physician-led menu across GLP-1 routes and adjacent longevity care, with transparent all-inclusive pricing and nationwide reach.
From $194/mo sema · $329/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: AlyveRx · RxSpan MD.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- AlyveRx vs CoreAge Rx
- RxSpan MD vs Vaylen
- AlyveRx vs Strut Health
- RxSpan MD vs Ondra Health
- AlyveRx vs Invigor Medical
- RxSpan MD vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.